On the other hand, the expression of MAGI2 and RP4-587D13.2 is downregulated in the duodenum of active CD patients and persists even after more than 2 years on GFD and an apparent recovery from intestinal atrophy, supporting a constitutive alteration that could have a genetic origin. The gene discussed is MAGI2; the disease is Atrophy.